• CAN-2409 Mechanism of Action
  • CAN-3110 Mechanism of Action
  • Careers
  • Investigator Login
Candel Therapeutics
  • About
  • Platforms
  • Pipeline
  • Patients
  • Investors
  • Media
  • News
  • Contact
  • Menu Menu

Off-The-Shelf Therapies For Individualized Cancer Response

The very best of both in a single cancer treatment

Candela is a unit of light

At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer

About

Designed to protect patients from cancer

Our investigational therapies are designed to produce a completely individualized response, specific to the patient and their cancer for long-lasting protection

Platforms
CAN-2409 Mechanism of Action
CAN-3110 Mechanism of Action

The patient is always our focal point

Our viral immunotherapies are being designed to have favorable benefit-to-risk profiles, in an effort to ensure patients have efficacious and well tolerated treatments across disease stages

Clinical Trials
Video on Candel’s Commitment to Patients

About

Platforms

Patients

© 2025 by Candel Therapeutics
Scroll to top Scroll to top Scroll to top